Episode Details

Following the FDA's removal of black box warnings for hormone therapy drugs, demand has skyrocketed for menopause treatments. In this episode: why this explosion in popularity marks a trend in the right direction for quality reproductive care while also raising concerns about "menowashed" products and blanket prescribing of hormonal interventions.

Dr. Wendy L. Bennett, MPH, is a primary care doctor and associate professor with appointments at the Johns Hopkins Bloomberg School of Public Health and School of Medicine.

Dr. Tina Zhang is a primary care doctor and assistant professor at the Johns Hopkins University School of Medicine.

Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs.

• Why the 'mad scramble' to fill hormone therapy prescriptions for menopause—NPR

• FACT SHEET: FDA Initiates Removal of "Black Box" Warnings from Menopausal Hormone Replacement Therapy Products—U.S. Department of Health and Human Services

• What Is a Black Box Warning?—Johns Hopkins Bloomberg School of Public Health

• De-medicalizing Menopause—Public Health On Call (March 2024)